Authors

• Angela Waszak
• Judy Wang (ORCID: https://orcid.org/0000-0002-7355-7542)
• James M. Cleary (ORCID: https://orcid.org/0000-0001-7213-3951)
• Ki Y. Chung (ORCID: https://orcid.org/0000-0001-6586-2013)
• Srimoyee Ghosh (ORCID: https://orcid.org/0000-0002-7820-6741)
• Iván Díaz-Padilla
• Shruti D. Shah
• Kaitlin Yablonski
• Richard D. Kim (ORCID: https://orcid.org/0000-0002-8448-844X)
• Susanna Varkey Ulahannan (ORCID: https://orcid.org/0000-0002-7234-2283)
• Omkar Marathe
• David J. Bajor
• Anuradha Krishnamurthy
• Hagop Youssoufian
• Hailei Zhang (ORCID: https://orcid.org/0000-0002-2600-112X)
• Gerald S. Falchook (ORCID: https://orcid.org/0000-0001-9165-2191)
• Amita Patnaik (ORCID: https://orcid.org/0000-0002-4144-2193)
• Catherine Ellis (ORCID: https://orcid.org/0009-0008-7635-7846)
• Jean‐Marie Michot (ORCID: https://orcid.org/0000-0003-3482-3331)
• J. Randolph Hecht

Institutions

• Prisma Health (US)
• Roswell Park Comprehensive Cancer Center (US)
• University of California, Los Angeles (US)
• University Hospitals of Cleveland (US)
• Institut Gustave Roussy (FR)
• Moffitt Cancer Center (US)
• Swiss Paediatric Oncology Group (CH)
• Sarah Cannon (US)
• GlaxoSmithKline (United States) (US)
• Dana-Farber Cancer Institute (US)
• South Texas Accelerated Research Therapeutics (US)
• HealthONE (US)
• Oncology Institute of Hope and Innovation (US)
• Oklahoma State University Oklahoma City (US)
• Case Western Reserve University (US)
• University of Oklahoma (US)

Publication Details

Journal

BJC Reports

Published

2025-02-27

DOI

https://doi.org/10.1038/s44276-024-00118-x

Citations

2

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

2.09